Charcot-Marie-Tooth disease

Changed by Hamish Smith, 15 May 2018

Updates to Article Attributes

Body was changed:

Charcot-Marie-Tooth (CMT) disease, also known as hereditary motor and sensory neuropathy (HMSN), is the most commonly inherited neuropathy of lower motor (to a lesser degree sensory) neurons.

Epidemiology

The prevalence of CMT in one Norwegian study was 82.3 cases per 100,000 people 4

Clinical presentation

Signs and symptoms usually become first evident in childhood. Typically this starts in the lower limbs with weakness, atrophy and deformity, and later affects the upper limbs. It rarely involves the more proximal musculature and rarely involves the cranial nerves. Sensory changes are present but usually to a lesser degree5.

Pathology

It is not a single condition, but a cluster of heterogeneous mutations with many subtypes, classified by which gene is affected. As expected the number and classification is in flux. Most frequently it is autosomal dominant in inheritance (although this is variable).

Classification

Classification is based on nerve-conduction studies and neuronal pathology divided into demyelinating and non-demyelinating forms 5:

Demyelinating forms

Reduced nerve conduction velocity (<38 m/sec) in upper limb nerves and myelin abnormalities on biopsy (e.g. onion bulb formation). This includes:

  • CMT type 1
    • this form of CMT disease is a disorderMost common4,5
    • Autosomal dominant inheritance, most commonly due to over-expression of peripheral myelinationmyelin protein 22 (PMP22)5
    • repeatedRepeated cycles of demyelination and remyelination result in a thick layer of abnormal myelin around the peripheral axons
    • theseThis form of CMT disease is a disorder of peripheral myelination
    • These changes cause what is referred to as an onion bulb appearance
  • CMT type 24
    • this primarily is a neuronal (i.e. axonalAutosomal recessive inheritance 5
Axonal forms

Preserved or mildly affected nerve conduction velocity (>38 m/s) disorder, not a demyelinating disorderand nerve biopsy evidence of degeneration and regeneration 5.

  • CMT type 2 results in peripheral
    • Peripheral neuropathy through direct axonal death and Wallerian degeneration
    • Autosomal dominant inheritance 5
    • Most commonly due to a mutation in the mitofusin 2 gene (MFN2) 5
Other forms
  • Pure motor neuropathy (dHMN) with sparing of sensory nerves
  • Pyramidal involvement (CMT type 5)
  • Optic nerve involvement (CMT type 6)
  • CMT type 3 (also known as Déjerine-Sottas disease)
    • characterizedCharacterised by infantile onset, this condition resultsresulting in severe demyelination with delayed motor skills;, it is much more severe than CMT type 1
    • Increased CSF protein and severe demyelination on nerve biopsy are features 5
  • X chromosome linked CMT X(CMTX) (X-linked
    • Second most common form of CMT overall  5
    • Most commonly due to a mutation in the gap-junction B1 (GJB1) and CMT 4: these are also demyelinating neuropathiesgene  5

Radiographic features

The nerve roots are typically hypertrophic with onion bulb sign. This represents hypertrophic demyelination. Denervation changes in muscles are apparent.

Some enhancement may be seen on MRI, but it is not usually a prominent feature.

Soft tissue and skeletal abnormalities (e.g. scoliosis) may also be noticeable .

Treatment and prognosis

Unfortunately no effective drug for CMT exists. Treatment is largely supportive with rehabilitation therapy and surgery for skeletal deformities 5. Most patients with CMT1A (the most common form of CMT) will remain able to walk for their entire life. However, the disease has variable severity depending on the subtype 5.

History and etymology

It is named after Jean-Martin Charcot, Pierre Marie and Howard Henry Tooth.

  • -<p><strong>Charcot-Marie-Tooth (CMT) disease</strong>, also known as <strong>hereditary motor and sensory neuropathy</strong> <strong>(HMSN)</strong>, is the most commonly inherited neuropathy of lower motor (to a lesser degree sensory) neurons.</p><h4>Clinical presentation</h4><p>Signs and symptoms usually become first evident in childhood. Typically this starts in the lower limbs with weakness, atrophy and deformity, and later affects the upper limbs. It rarely involves the more proximal musculature and rarely involves the cranial nerves. Sensory changes are present but usually to a lesser degree.</p><h4>Pathology</h4><p>It is not a single condition, but a cluster of heterogeneous mutations with many subtypes, classified by which gene is affected. As expected the number and classification is in flux. Most frequently it is <a href="/articles/autosomal-dominant">autosomal dominant</a> in inheritance (although this is variable).</p><h5>Classification</h5><ul>
  • +<p><strong>Charcot-Marie-Tooth (CMT) disease</strong>, also known as <strong>hereditary motor and sensory neuropathy</strong> <strong>(HMSN)</strong>, is the most commonly inherited neuropathy of lower motor (to a lesser degree sensory) neurons.</p><h4>Epidemiology</h4><p>The prevalence of CMT in one Norwegian study was 82.3 cases per 100,000 people <sup>4</sup>. </p><h4>Clinical presentation</h4><p>Signs and symptoms usually become first evident in childhood. Typically this starts in the lower limbs with weakness, atrophy and deformity, and later affects the upper limbs. It rarely involves the more proximal musculature and rarely involves the cranial nerves. Sensory changes are present but usually to a lesser degree <sup>5</sup>.</p><h4>Pathology</h4><p>It is not a single condition, but a cluster of heterogeneous mutations with many subtypes. As expected the number and classification is in flux. Most frequently it is <a href="/articles/autosomal-dominant">autosomal dominant</a> in inheritance (although this is variable).</p><h5>Classification</h5><p>Classification is based on nerve-conduction studies and neuronal pathology divided into demyelinating and non-demyelinating forms <sup>5</sup>:</p><h6>Demyelinating forms</h6><p>Reduced nerve conduction velocity (&lt;38 m/sec) in upper limb nerves and myelin abnormalities on biopsy (e.g. onion bulb formation). This includes:</p><ul>
  • -<strong>CMT type 1</strong><ul>
  • -<li>this form of CMT disease is a disorder of peripheral myelination</li>
  • -<li>repeated cycles of demyelination and remyelination result in a thick layer of abnormal myelin around the peripheral axons</li>
  • -<li>these changes cause what is referred to as an <a href="/articles/onion-bulb-formation">onion bulb appearance</a>
  • +<strong>CMT type 1​</strong><ul>
  • +<li>Most common<sup>4,5</sup>
  • +</li>
  • +<li>Autosomal dominant inheritance, most commonly due to over-expression of peripheral myelin protein 22 (PMP22)<sup>5</sup>
  • +</li>
  • +<li>Repeated cycles of demyelination and remyelination result in a thick layer of abnormal myelin around the peripheral axons</li>
  • +<li>This form of CMT disease is a disorder of peripheral myelination</li>
  • +<li>These changes cause what is referred to as an <a href="/articles/onion-bulb-formation">onion bulb appearance</a>
  • -<strong>CMT type 2</strong><ul><li>this primarily is a neuronal (i.e. axonal) disorder, not a demyelinating disorder. CMT type 2 results in peripheral neuropathy through direct axonal death and Wallerian degeneration</li></ul>
  • +<strong>CMT type 4</strong><ul><li>Autosomal recessive inheritance <sup>5</sup>
  • +</li></ul>
  • -<li>
  • -<strong>CMT type 3</strong> (also known as <a href="/articles/dejerine-sottas-disease-3">Déjerine-Sottas disease</a>)<ul><li>characterized by infantile onset, this condition results in severe demyelination with delayed motor skills; it is much more severe than type 1</li></ul>
  • +</ul><h6>Axonal forms</h6><p>Preserved or mildly affected nerve conduction velocity (&gt;38 m/s) and nerve biopsy evidence of degeneration and regeneration <sup>5</sup>.</p><ul><li>
  • +<strong>CMT type 2</strong><ul>
  • +<li>Peripheral neuropathy through direct axonal death and Wallerian degeneration</li>
  • +<li>Autosomal dominant inheritance <sup>5</sup>
  • +<li>Most commonly due to a mutation in the mitofusin 2 gene (MFN2) <sup>5</sup>
  • +</li>
  • +</ul>
  • +</li></ul><h6>Other forms</h6><ul>
  • +<li>Pure motor neuropathy (<strong>dHMN</strong>) with sparing of sensory nerves</li>
  • +<li>Pyramidal involvement (<strong>CMT type 5</strong>)</li>
  • +<li>Optic nerve involvement (<strong>CMT type 6</strong>)</li>
  • -<strong>CMT X</strong> (X-linked CMT) and <strong>CMT 4</strong>: these are also demyelinating neuropathies</li>
  • -</ul><h4>Radiographic features</h4><p>The nerve roots are typically hypertrophic with <a href="/articles/onion-bulb-formation">onion bulb sign</a>. This represents hypertrophic demyelination. <a href="/articles/denervation-changes-in-muscles">Denervation changes in muscles</a> are apparent.</p><p>Some enhancement may be seen on MRI, but it is not usually a prominent feature.</p><h4>History and etymology</h4><p>It is named after <strong>Jean-Martin Charcot</strong>, <strong>Pierre Marie</strong> and <strong>Howard Henry Tooth.</strong></p>
  • +<strong>CMT type 3</strong> (also known as <a href="/articles/dejerine-sottas-disease-3">Déjerine-Sottas disease</a>)<ul>
  • +<li>Characterised by infantile onset, resulting in severe demyelination with delayed motor skills, it is much more severe than CMT type 1</li>
  • +<li>Increased CSF protein and severe demyelination on nerve biopsy are features <sup>5</sup>
  • +</li>
  • +</ul>
  • +</li>
  • +<li>X chromosome linked CMT (<strong>CMTX</strong>) <ul>
  • +<li>Second most common form of CMT overall  <sup>5</sup>
  • +</li>
  • +<li>Most commonly due to a mutation in the gap-junction B1 (GJB1) gene  <sup>5</sup>
  • +</li>
  • +</ul>
  • +</li>
  • +</ul><h4>Radiographic features</h4><p>The nerve roots are typically hypertrophic with <a href="/articles/onion-bulb-formation">onion bulb sign</a>. This represents hypertrophic demyelination. <a href="/articles/denervation-changes-in-muscles">Denervation changes in muscles</a> are apparent.</p><p>Some enhancement may be seen on MRI, but it is not usually a prominent feature.</p><p>Soft tissue and skeletal abnormalities (e.g. <a title="Scoliosis" href="/articles/scoliosis">scoliosis</a>) may also be noticeable .</p><h4>Treatment and prognosis</h4><p>Unfortunately no effective drug for CMT exists. Treatment is largely supportive with rehabilitation therapy and surgery for skeletal deformities <sup>5</sup>. Most patients with CMT1A (the most common form of CMT) will remain able to walk for their entire life. However, the disease has variable severity depending on the subtype <sup>5</sup>.</p><h4>History and etymology</h4><p>It is named after <strong>Jean-Martin Charcot</strong>, <strong>Pierre Marie</strong> and <strong>Howard Henry Tooth</strong>.</p>

References changed:

  • 4. Lidiane Carine Lima Santos Barreto, Fernanda Santos Oliveira, Paula Santos Nunes, Iandra Maria Pinheiro de França Costa, Catarina Andrade Garcez, Gabriel Mattos Goes, Eduardo Luis Aquino Neves, Jullyana de Souza Siqueira Quintans, Adriano Antunes de Souza Araújo. Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review. (2018) Neuroepidemiology. 46 (3): 157. <a href="https://doi.org/10.1159/000443706">doi:10.1159/000443706</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/26849231">Pubmed</a> <span class="ref_v4"></span>
  • 5. Pareyson D & Marchesi C. Diagnosis, Natural History, and Management of Charcot-Marie-Tooth Disease. Lancet Neurol. 2009;8(7):654-67. <a href="https://doi.org/10.1016/S1474-4422(09)70110-3">doi:10.1016/S1474-4422(09)70110-3</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19539237">Pubmed</a>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.